Indoco Remedies has secured US Food & Drug Administration approval to manufacture and sell the generic of Zyloprim tablets, the company said in an exchange filing on Friday. Indoco Remedies will sell the generic allopurinol tablets in 100 mg and 300 mg strengths. Allopurinol is primarily used in the treatment of excess uric acid in blood. Shares of Indoco Remedies were down 4.8 per cent at ₹307.20 on the NSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.